MDMA-assisted Massed Prolonged Exposure for PTSD
The overall objective of this study is to pilot the VASDHS-adapted Emory MDMA-PE Protocol (aE-MDMA-PE) and assess the effect on clinician-rated PTSD symptoms in veterans who receive different doses of MDMA.
- Status
- recruiting
- Phase
- Phase 3
- Institution
- Healing Breakthrough
- Principal investigator
- Leslie Morland, Psy.D.
- Start date
- 2024-10-25
- End date
- 2027-08-31
- Registry ID
- NCT06117306
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.